After emerging from the shadows with a $100 million Series A in April, Seaport Therapeutics has moved swiftly to shore up its finances with a $225 million second round to fund the development of ...
JHancock Seaport Long/ Short Fund earns a Below Average Process Pillar rating. The process benefits from the scale of its portfolio management team. With five portfolio managers at the helm ...
After hours: February 18 at 6:25:53 PM EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback